This is a patent on generation of neutrophil precursors and their expansion ex vivo. It may be interesting to use a patent such as this to generate allogeneic neutrophils for short term use after chemotherapy for patients that are immunocompromised so that they do not get infections.
The question is whether administration of such allogeneic neutrophils would cause nephritis by virtue of formation of antigen antibody complexes.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.